Assay Kits_abinScience

Avelumab (3)

NP/Nucleoprotein (3)

Lorvotuzumab (1)

Spike glycoprotein E2 (2)

Tiragolumab (2)

Lacnotuzumab (1)

Anetumab (1)

Clazakizumab (1)

Ivuxolimab (1)

F/Fusion glycoprotein F0 (5)

Basiliximab (1)

Varlilumab (1)

Eculizumab (3)

Nesvacumab (1)

Zalifrelimab (1)

Edrecolomab (1)

Durvalumab (3)

IL1RL1/ST2 (1)

Tisotumab (1)

Spike glycoprotein E1 (2)

Enoblituzumab (1)

Sacituzumab (1)

RBD (Omicron/BA.4/BA.5) (1)

Ontamalimab (1)

Olokizumab (1)

Pogalizumab (1)

Guselkumab (2)

Camidanlumab (1)

Talacotuzumab (1)

Denosumab (3)

Vanucizumab (1)

Lupartumab (1)

Rolinsatamab (1)

Pacmilimab (1)

cAMP (1)

Imalumab (1)

dsRNA (1)

Mirzotamab (1)

Semorinemab (1)

Semaglutide (1)

Glembatumumab (1)

Sirukumab (1)

Tavolimab (1)

Elotuzumab (1)

Daclizumab (1)

Vibecotamab (1)

Cetuximab (3)

Sarilumab (2)

Depatuxizumab (1)

Anifrolumab (1)

Nirsevimab (1)

cGMP (1)

Andecaliximab (1)

ATP7B (1)

Omburtamab (1)

Tilavonemab (1)

B6R/SL-159 (1)

Balstilimab (1)

Ziltivekimab (1)

Lirilumab (1)

Evolocumab (1)

Ibalizumab (1)

Bimagrumab (1)

Daratumumab (3)

Ustekinumab (3)

Losatuxizumab (1)

Icrucumab (1)

Palivizumab (3)

BSA (1)

Farletuzumab (1)

TPP15 (1)

Frovocimab (1)

Nivolumab (5)

Zagotenemab (1)

RBD (Omicron/JN.1) (1)

Cetrelimab (1)

Cergutuzumab (1)

Codrituzumab (1)

Alirocumab (1)

Tregalizumab (1)

Ifabotuzumab (1)

Omalizumab (2)

Necitumumab (1)

Ieramilimab (1)

Suptavumab (1)

Protein A (1)

Mirvetuximab (1)

TPP17 (1)

Lodelcizumab (1)

Etanercept (3)

Befovacimab (1)

RBD (Omicron/KP.2) (1)

Pembrolizumab (3)

Labetuzumab (1)

Astegolimab (1)

RBD (Omicron/BA.5) (3)

Zanolimumab (1)

dsDNA (1)

Eldelumab (1)

Letolizumab (1)

RBD (6)

Panitumumab (3)

Mavezelimab (1)

Suvizumab (1)

Human β Amyloid (1-42) (1)

Bevacizumab (3)

TPP47 (1)

Tezepelumab (1)

RBD (WT) (1)

Concizumab (1)

CD340/ERBB2 (1)

Sintilimab (1)

Cabiralizumab (1)

Belantamab (1)

Glycoprotein (5)

Lenzilumab (1)

Itolizumab (1)

Spike glycoprotein (9)

Serclutamab (1)

Favezelimab (1)

Foravirumab (1)

Human β Amyloid (1-40) (1)

Brolucizumab (1)

G/Major surface glycoprotein G (1)

Elezanumab (1)

RBD (Alpha) (1)

Marstacimab (1)

M/Matrix protein (2)

Tislelizumab (1)

Emactuzumab (1)

Teclistamab (1)

Pasotuxizumab (1)

GP/Envelope glycoprotein (4)

Namilumab (1)

Cusatuzumab (1)

Spike Protein (Trimer) (2)

Tesidolumab (1)

Indatuximab (1)

Rafivirumab (1)

TAU pT181 (1)

Ranibizumab (3)

N/Nucleoprotein (1)

Enfortumab (1)

RBD (Beta) (1)

Obinutuzumab (2)

gG/US4 (2)

Toripalimab (1)

Cixutumumab (1)

Dalotuzumab (1)

Rosopatamab (2)

Tirzepatide (2)

Otilimab (1)

Vorsetuzumab (1)

NP/Nucleocapsid (5)

Tanezumab (1)

Lintuzumab (1)

Tosatoxumab (1)

TAU pT217 (1)

Varisacumab (1)

Spike glycoprotein (RBD) (1)

Ianalumab (1)

RBD (Gamma) (1)

Afutuzumab (1)

gB/Envelope glycoprotein B (1)

Afasevikumab (1)

Figitumumab (1)

Tarextumab (1)

Simlukafusp Alfa (1)

Milatuzumab (1)

Meplazumab (1)

Rituximab (1)

Adalimumab (3)

Oleclumab (1)

Obiltoxaximab (1)

Benufutamab (1)

Crizanlizumab (1)

EPO/Erythropoietin (1)

Blosozumab (1)

RBD (E484K) (1)

Epcoritamab (1)

gE/Envelope glycoprotein E (1)

Bimekizumab (1)

Ixekizumab (1)

Ganitumab (1)

Urelumab (1)

IL6 (1)

Disitamab (1)

Alacizumab (1)

Natalizumab (2)

Certolizumab (2)

Zampilimab (1)

Gremubamab (1)

Conatumumab (1)

Inclacumab (1)

Romosozumab (1)

RBD (Kappa) (1)

Glofitamab (1)

gD/Envelope glycoprotein D (1)

gC/Envelope glycoprotein C (1)

Remtolumab (1)

Teprotumumab (1)

Utomilumab (1)

Aflibercept (1)

Pertuzumab (3)

Ramucirumab (1)

Romiplostim (2)

Golimumab (2)

Vofatamab (1)

M1R (5)

Drozitumab (1)

Olaratumab (1)

Mirikizumab (2)

RBD (Delta Plus) (1)

Ibritumomab (1)

Mosunetuzumab (1)

gC/UL44 (1)

Secukinumab (2)

Apamistamab (1)

Magrolimab (1)

sCD14 (1)

Trastuzumab (2)

Ascrinvacumab (1)

Sotrovimab (1)

Infliximab (2)

Oxelumab (1)

H3L (3)

Lexatumumab (1)

Tovetumab (1)

Dilpacimab (1)

RBD (Delta) (3)

Ocaratuzumab (1)

gD/US6 (1)

Tibulizumab (1)

Emibetuzumab (1)

Sibrotuzumab (1)

Zanidatamab (1)

Cinpanemab (1)

Casirivimab (1)

Canakinumab (1)

Dupilumab (3)

E8L (5)

Tigatuzumab (1)

Ipilimumab (2)

Navicixizumab (1)

A29L (6)

Atezolizumab (3)

SARS-CoV-2 Neutralization Antibody (3)

Carlumab (1)

US8/gE (1)

Vunakizumab (1)

Tocilizumab (3)

Amatuximab (1)

Zenocutuzumab (1)

CD79B (2)

Imdevimab (1)

Gevokizumab (1)

Iscalimab (1)

A35R (5)

Faricimab (1)

Tremelimumab (1)

Recombinant Proteins

Antibodies

Assay Kits

Sample type

Range

Sample type

Range

Sample type

Range

Sample type

Range

Sample type

Range

Sample type

Range

Sample type

Sensitivity

Range

Sample type

Range

Sample type

Range

Sample type

Range

Quick access

Contact us